Kazuo Sugamura Selected Research

Kazuo Sugamura Research Topics

Disease

21	Neoplasms (Cancer) 08/2022 - 01/2002
6	Infections 04/2009 - 03/2003
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2022 - 01/2019
3	Cholangiocarcinoma 01/2021 - 06/2014
3	Hypopharyngeal Neoplasms 10/2019 - 01/2013
3	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 01/2013 - 03/2006
3	Inflammation (Inflammations) 04/2010 - 08/2003
3	Hypoxia (Hypoxemia) 01/2009 - 03/2006
3	Pulmonary Hypertension 01/2009 - 03/2006
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 03/2017 - 05/2016
2	Carcinogenesis 02/2015 - 06/2007
2	Atherosclerosis 12/2010 - 04/2005
2	Necrosis 12/2010 - 10/2004
2	Neoplasm Metastasis (Metastasis) 08/2008 - 06/2007
2	Contact Dermatitis (Eczema, Contact) 08/2006 - 11/2002
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2002 - 06/2002
1	Esophageal Neoplasms (Esophageal Cancer) 08/2022
1	Carcinoma (Carcinomatosis) 04/2020
1	Melanoma (Melanoma, Malignant) 10/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Adenocarcinoma 01/2019
1	Lymphoma (Lymphomas) 03/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2013
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 01/2012
1	Leukemia 01/2012
1	Atherosclerotic Plaque (Atheroma) 12/2010
1	Hepatocellular Carcinoma (Hepatoma) 10/2010
1	Autoimmune Diseases (Autoimmune Disease) 09/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 09/2010
1	Ovarian Neoplasms (Ovarian Cancer) 09/2009
1	Pulmonary Arterial Hypertension 01/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2008
1	Ischemia 03/2007

Drug/Important Bio-Agent (IBA)

6	Adapalene (Differin)FDA LinkGeneric 08/2022 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 08/2022 - 06/2006
5	LigandsIBA 06/2014 - 11/2002
4	OX40 LigandIBA 12/2010 - 04/2003
4	CytokinesIBA 04/2010 - 04/2003
3	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 08/2022 - 01/2016
3	Monoclonal AntibodiesIBA 08/2022 - 10/2003
2	Glycoproteins (Glycoprotein)IBA 08/2022 - 04/2020
2	Small Interfering RNA (siRNA)IBA 04/2020 - 06/2007
2	AntibodiesIBA 02/2020 - 09/2010
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2013
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2013 - 05/2006
2	AllergensIBA 04/2010 - 04/2003
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2009 - 03/2007
2	Erythropoietin FDA Link 03/2007 - 03/2006
2	HaptensIBA 08/2006 - 11/2002
2	Prostaglandins DIBA 08/2006 - 08/2003
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 06/2002 - 02/2002
1	ErbB Receptors (EGF Receptor)IBA 08/2022
1	nanolucIBA 01/2021
1	bis(4-methylumbelliferyl)pyrophosphateIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 12/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 12/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2020
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 04/2020
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 10/2019
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2017
1	Carbonic Anhydrase IXIBA 03/2017
1	MK 2206IBA 05/2016
1	MicroRNAs (MicroRNA)IBA 02/2015
1	Long Noncoding RNAIBA 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	Apolipoproteins E (ApoE)IBA 12/2010
1	Epithelial Cell Adhesion MoleculeIBA 10/2010
1	Biological ProductsIBA 10/2010
1	Rituximab (Mabthera)FDA Link 09/2010
1	LuciferasesIBA 09/2009
1	Proanthocyanidins (Procyanidins)IBA 04/2009
1	Butanols (Butyl Alcohols)IBA 04/2009
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2009
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009
1	alpha-galactosylceramideIBA 08/2008
1	Endosomal Sorting Complexes Required for TransportIBA 07/2008
1	beta CateninIBA 06/2007
1	Phosphotransferases (Kinase)IBA 06/2007
1	tyrosine receptor (receptor, tyrosine)IBA 06/2007
1	Cadherins (E-Cadherin)IBA 06/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2007
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 03/2007
1	Immunoglobulin E (IgE)IBA 08/2006
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 08/2006
1	prostaglandin D2 receptorIBA 08/2006
1	Prostaglandin D2IBA 08/2006
1	Immunoglobulin M (IgM)IBA 08/2006
1	Immunoglobulin G (IgG)IBA 08/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2006
1	Thymidine KinaseIBA 03/2006
1	Ganciclovir (Cytovene)FDA LinkGeneric 03/2006
1	Complementary DNA (cDNA)IBA 03/2006
1	Interleukin-2 (IL2)IBA 09/2005

Therapy/Procedure

4	Therapeutics 12/2020 - 10/2004
3	Transplantation 05/2016 - 03/2007
2	Heterologous Transplantation (Xenotransplantation) 05/2016 - 11/2002
2	Immunotherapy 05/2004 - 02/2002
1	Drug Therapy (Chemotherapy) 01/2021